These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17947700)

  • 41. Biomechanical signals inhibit IKK activity to attenuate NF-kappaB transcription activity in inflamed chondrocytes.
    Dossumbekova A; Anghelina M; Madhavan S; He L; Quan N; Knobloch T; Agarwal S
    Arthritis Rheum; 2007 Oct; 56(10):3284-96. PubMed ID: 17907174
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nodakenin suppresses lipopolysaccharide-induced inflammatory responses in macrophage cells by inhibiting tumor necrosis factor receptor-associated factor 6 and nuclear factor-κB pathways and protects mice from lethal endotoxin shock.
    Rim HK; Cho W; Sung SH; Lee KT
    J Pharmacol Exp Ther; 2012 Sep; 342(3):654-64. PubMed ID: 22637723
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tetrandrine suppresses LPS-induced astrocyte activation via modulating IKKs-IkappaBalpha-NF-kappaB signaling pathway.
    Lin ST; Wang Y; Xue Y; Feng DC; Xu Y; Xu LY
    Mol Cell Biochem; 2008 Aug; 315(1-2):41-9. PubMed ID: 18498042
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro study of inhibitory millimeter wave treatment effects on the TNF-α-induced NF-κB signal transduction pathway.
    Li X; Wu G; Wu M; Chen W; Liu X
    Int J Mol Med; 2011 Jan; 27(1):71-8. PubMed ID: 21069255
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biomechanical thresholds regulate inflammation through the NF-kappaB pathway: experiments and modeling.
    Nam J; Aguda BD; Rath B; Agarwal S
    PLoS One; 2009; 4(4):e5262. PubMed ID: 19370157
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vivo pro- and anti-inflammatory cytokines in normal and patients with rheumatoid arthritis.
    Sivalingam SP; Thumboo J; Vasoo S; Thio ST; Tse C; Fong KY
    Ann Acad Med Singap; 2007 Feb; 36(2):96-9. PubMed ID: 17364074
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Artificial cartilage: weaving in three dimensions.
    Ateshian GA
    Nat Mater; 2007 Feb; 6(2):89-90. PubMed ID: 17268489
    [No Abstract]   [Full Text] [Related]  

  • 48. Treatment of rheumatoid arthritis.
    Gaffo A; Saag KG; Curtis JR
    Am J Health Syst Pharm; 2006 Dec; 63(24):2451-65. PubMed ID: 17158693
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biomechanical signals suppress proinflammatory responses in cartilage: early events in experimental antigen-induced arthritis.
    Ferretti M; Gassner R; Wang Z; Perera P; Deschner J; Sowa G; Salter RB; Agarwal S
    J Immunol; 2006 Dec; 177(12):8757-66. PubMed ID: 17142778
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The pathogenesis of rheumatoid arthritis.
    Weissmann G
    Bull NYU Hosp Jt Dis; 2006; 64(1-2):12-5. PubMed ID: 17121483
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biologic therapies on the horizon for rheumatoid arthritis.
    Moreland LW
    J Clin Rheumatol; 2004 Jun; 10(3 Suppl):S32-9. PubMed ID: 17043499
    [TBL] [Abstract][Full Text] [Related]  

  • 52. IKKbeta inhibition protects against bone and cartilage destruction in a rat model of rheumatoid arthritis.
    Schopf L; Savinainen A; Anderson K; Kujawa J; DuPont M; Silva M; Siebert E; Chandra S; Morgan J; Gangurde P; Wen D; Lane J; Xu Y; Hepperle M; Harriman G; Ocain T; Jaffee B
    Arthritis Rheum; 2006 Oct; 54(10):3163-73. PubMed ID: 17009244
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Amelioration of arthritis by intraarticular dominant negative Ikk beta gene therapy using adeno-associated virus type 5.
    Tas SW; Adriaansen J; Hajji N; Bakker AC; Firestein GS; Vervoordeldonk MJ; Tak PP
    Hum Gene Ther; 2006 Aug; 17(8):821-32. PubMed ID: 16942442
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biologics in development for rheumatoid arthritis: relevance to osteoarthritis.
    Abramson SB; Yazici Y
    Adv Drug Deliv Rev; 2006 May; 58(2):212-25. PubMed ID: 16567019
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Persistent interleukin-1beta signaling causes long term activation of NFkappaB in a promoter-specific manner in human glial cells.
    Griffin BD; Moynagh PN
    J Biol Chem; 2006 Apr; 281(15):10316-26. PubMed ID: 16455661
    [TBL] [Abstract][Full Text] [Related]  

  • 56. NF-kappaBp65-specific siRNA inhibits expression of genes of COX-2, NOS-2 and MMP-9 in rat IL-1beta-induced and TNF-alpha-induced chondrocytes.
    Lianxu C; Hongti J; Changlong Y
    Osteoarthritis Cartilage; 2006 Apr; 14(4):367-76. PubMed ID: 16376111
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regulation of matrix metalloproteinase expression by dynamic tensile strain in rat fibrochondrocytes.
    Deschner J; Rath-Deschner B; Agarwal S
    Osteoarthritis Cartilage; 2006 Mar; 14(3):264-72. PubMed ID: 16290189
    [TBL] [Abstract][Full Text] [Related]  

  • 58. TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo.
    Shim JH; Xiao C; Paschal AE; Bailey ST; Rao P; Hayden MS; Lee KY; Bussey C; Steckel M; Tanaka N; Yamada G; Akira S; Matsumoto K; Ghosh S
    Genes Dev; 2005 Nov; 19(22):2668-81. PubMed ID: 16260493
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The NF-kappaB pathway.
    Moynagh PN
    J Cell Sci; 2005 Oct; 118(Pt 20):4589-92. PubMed ID: 16219681
    [No Abstract]   [Full Text] [Related]  

  • 60. Anti-inflammatory effects of continuous passive motion on meniscal fibrocartilage.
    Ferretti M; Srinivasan A; Deschner J; Gassner R; Baliko F; Piesco N; Salter R; Agarwal S
    J Orthop Res; 2005 Sep; 23(5):1165-71. PubMed ID: 16140197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.